Associated Papers
Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA.
Riviere-Cazaux C et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2025
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel.
Maloberti T et al.
Diagnostics (basel, Switzerland), 2024
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.
Orzan F et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2023
TERT Mutations in Non-Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications.
Yang L et al.
Clinical Medicine Insights. Oncology, 2023
Mutational Signature and Integrative Genomic Analysis of Human Papillomavirus-Associated Penile Squamous Cell Carcinomas from Latin American Patients.
Canto LM et al.
Cancers, 2022
Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
Kim H et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2022
Detection of TERT Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error.
Lee H et al.
Cancer Research and Treatment, 2022
Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas.
Udugama M et al.
Nature Communications, 2021
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.
da Silva EM et al.
Npj Breast Cancer, 2021
TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients.
Pandey R et al.
Cancers, 2021
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma.
Maturo MG et al.
Scientific Reports, 2020
Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach.
D'Afonseca V et al.
Cancer Informatics, 2020
The landscape of genomic alterations across childhood cancers.
Gröbner SN et al.
Nature, 2018
Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder.
Rodriguez Pena MDC et al.
Virchows Archiv : an International Journal of Pathology, 2017
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer.
Chien J et al.
Nucleic Acids Research, 2015
TP53 mutants in the tower of babel of cancer progression.
Bisio A et al.
Human Mutation, 2014